<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01249963</url>
  </required_header>
  <id_info>
    <org_study_id>ATEM2010</org_study_id>
    <secondary_id>Atémpero IDI-20080283</secondary_id>
    <nct_id>NCT01249963</nct_id>
  </id_info>
  <brief_title>Enteral Nutrition Product in Mild Acute Pancreatitis</brief_title>
  <official_title>Evaluation of Oral Enteral Nutrition Supplement in Patients With Mild Acute Pancreatitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vegenat, S.A.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vegenat, S.A.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to evaluate the beneficial effects of the administration of enteral
      nutrition product with milk proteins, monounsaturated fatty acids and low dextrose equivalent
      maltodextrin and enriched in eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and
      medium chain triglycerides (MCT) in patients with mild acute pancreatitis. All this against
      other specific product.

      The main objectives of this project are:

        -  Comparing the tolerance of both preparations.

        -  Comparing the evolution of nutritional status in both groups.

        -  Comparing the evolution of inflammatory parameters in both groups
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Oral administration of an oligomeric formula with milk proteins, mainly whey protein
      partially hydrolysate, monounsaturated fatty acids (AGM) and low dextrose equivalent
      maltodextrin and enriched in polyunsaturated fatty acids (PUFA) of omega-3 series, EPA and
      DHA, and MCT designed for nutritional support of patients with compromised intestinal
      function, to maintain or improve nutritional status and reduce the inflammatory response in
      undernourished patients with mild acute pancreatitis, compared with oligomeric enteral
      nutrition product, low in fat and rich in glutamine.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2011</start_date>
  <completion_date type="Anticipated">March 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Acceptance, Tolerance and Nutritional Status</measure>
    <time_frame>1 year</time_frame>
    <description>To compare the acceptance and tolerance of both products.
To compare the nutritional status in both arms.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Inflammatory parameters evolution and EN complications</measure>
    <time_frame>1 year</time_frame>
    <description>To compare the inflammatory parameters evolution in both arms.
To evaluate the enteral nutrition complications.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Acute Pancreatitis</condition>
  <condition>Enteral Nutrition</condition>
  <arm_group>
    <arm_group_label>Experimental Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients of this group will receive 400 ml per day of T-Diet plus Atémpero product during 28 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients of this group will receive 2 packets (76 g) per day of AlitraQ (Abbott) product during 28 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>T-Diet plus Atémpero</intervention_name>
    <description>T-Diet plus Atémpero is a complete normocaloric and normoproteic enteral nutrition product for the dietary management of patients with mild acute pancreatitis.</description>
    <arm_group_label>Experimental Group</arm_group_label>
    <other_name>ATEMP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>AlitraQ (Abbott)</intervention_name>
    <description>AlitraQ is a nutritional product for patients with impaired gastrointestinal function.For oral or tube nutrition. Enriched with glutamine and arginine.</description>
    <arm_group_label>Control Diet</arm_group_label>
    <other_name>ALIT</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients over 18 with Mild Acute Pancreatitis.

        Exclusion Criteria:

          -  Patients with Several Acute Pancreatitis

          -  Patients with life expectancy less than 48 hours.

          -  Renal (creatinin &gt; 2,5 mg/dl) or kidney failure (GOT/GPT&gt;2 from laboratory normal
             value)

          -  Patients with diabetes mellitus prior to acute pancreatitis.

          -  To take part in another study.

          -  Pregnant patients

          -  Informed consent absence.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pilar García-Peris, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario Gregorio Marañón</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Cristina Velasco Gimeno, BA</last_name>
    <phone>+34 91 586 71 64</phone>
    <email>cvelasco.hgugm@salud.madrid.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Clinical Nutrition and Dietetic Unit, Hospital Universitario Gregorio Marañón</name>
      <address>
        <city>Madrid</city>
        <zip>28007</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cristina Velasco Gimeno, BA</last_name>
      <phone>+34 91 586 71 64</phone>
      <email>cvelasco.hgugm@salud.madrid.org</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>February 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 26, 2010</study_first_submitted>
  <study_first_submitted_qc>November 26, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 30, 2010</study_first_posted>
  <last_update_submitted>June 21, 2012</last_update_submitted>
  <last_update_submitted_qc>June 21, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 22, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>acute pancreatitis</keyword>
  <keyword>enteral nutrition</keyword>
  <keyword>nutritional status</keyword>
  <keyword>pancreas</keyword>
  <keyword>T-Diet plus Atémpero</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Phentermine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

